Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort
- PMID: 33610053
- PMCID: PMC11149831
- DOI: 10.1016/j.envint.2021.106442
Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort
Abstract
Background: Previous studies of association between exposure to poly- and perfluoroalkyl substances (PFAS) and gestational hypertension (GH) and preeclampsia (PE) have shown conflicting results, but most dichotomized outcome and did not study continuous blood pressure (BP) changes.
Objectives: To study the association between PFAS exposure in early pregnancy and maternal BP trajectories in pregnancy, gestational hypertension and preeclampsia.
Methods: 1436 women were enrolled in the Odense Child Cohort in early pregnancy and had a serum sample drawn, from which perfluorohexane sulfonic acid (PFHxS), perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA) and perfluorodecanoic acid (PFDA) were measured using LC-MS/MS. Repeated BP measurements through pregnancy and information on PE were obtained from hospital files. Adjusted linear mixed models were used to investigate association between PFAS exposure and BP trajectory. Associations between PFAS and PE and GH were assessed by Cox proportional hazards model.
Results: All women had measurable concentrations of PFAS. In all of many comparisons higher PFAS exposure (apart from PFHxS) was associated with higher systolic (SBP) and diastolic (DBP) blood pressures, although not all were significant, which is unlikely to be due to chance. After adjustment, each doubling in PFOS or PFOA exposure was associated with 0.47 mmHg (95% CI: -0.13; 1.08) and 0.36 mmHg (-0.19; 0.92) higher SBP; and 0.58 mmHg (0.13; 1.04) and 0.37 mmHg (-0.05; 0.79) higher DBP. No clear associations between PFAS exposure and PE or GH were found.
Discussion: The magnitude of the association between PFAS exposure and BP might appear small, statistically non-significant and the possible clinical importance low. However, at a population level this may slightly shift the distribution of BP towards an increased incidence of GH. If BP increases in pregnancy, it may have long-term impact on health not only of the pregnant woman but also of her offspring.
Keywords: Blood pressure; Environmental chemicals; Perfluoroalkyl substances (PFAS); Preeclampsia; Pregnancy.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Prenatal and early postnatal exposure to perfluoroalkyl substances and bone mineral content and density in the Odense Child Cohort.Environ Int. 2023 Nov;181:108264. doi: 10.1016/j.envint.2023.108264. Epub 2023 Oct 13. Environ Int. 2023. PMID: 37864903
-
Higher free thyroxine associated with PFAS exposure in first trimester. The Odense Child Cohort.Environ Res. 2022 Sep;212(Pt D):113492. doi: 10.1016/j.envres.2022.113492. Epub 2022 May 18. Environ Res. 2022. PMID: 35597289
-
Prenatal and early postnatal exposure to perfluoroalkyl substances and bone mineral content and density in the Odense child cohort.Environ Int. 2022 Sep;167:107417. doi: 10.1016/j.envint.2022.107417. Epub 2022 Jul 16. Environ Int. 2022. Retraction in: Environ Int. 2023 Nov;181:108275. doi: 10.1016/j.envint.2023.108275. PMID: 35914335 Retracted.
-
Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.Environ Int. 2023 Feb;172:107734. doi: 10.1016/j.envint.2023.107734. Epub 2023 Jan 7. Environ Int. 2023. PMID: 36764183
-
Perfluoroalkyl and polyfluoroalkyl substances and hypertensive disorders of pregnancy: A systematic review and meta-analysis.Environ Res. 2023 Aug 15;231(Pt 2):116064. doi: 10.1016/j.envres.2023.116064. Epub 2023 May 11. Environ Res. 2023. PMID: 37178750
Cited by
-
Unveiling the Research Void: Exploring the Reproductive Effects of PFAS Compounds on Male Health.Adv Exp Med Biol. 2025;1469:127-162. doi: 10.1007/978-3-031-82990-1_7. Adv Exp Med Biol. 2025. PMID: 40301256 Review.
-
Developmental toxicant exposures and sex-specific effects on epigenetic programming and cardiovascular health across generations.Environ Epigenet. 2022 Oct 3;8(1):dvac017. doi: 10.1093/eep/dvac017. eCollection 2022. Environ Epigenet. 2022. PMID: 36325489 Free PMC article. Review.
-
A review of cardiovascular effects and underlying mechanisms of legacy and emerging per- and polyfluoroalkyl substances (PFAS).Arch Toxicol. 2023 May;97(5):1195-1245. doi: 10.1007/s00204-023-03477-5. Epub 2023 Mar 22. Arch Toxicol. 2023. PMID: 36947184 Review.
-
Per- and polyfluoroalkyl substances in drinking water and hypertensive disorders of pregnancy in the United States during 2013-2015.Environ Epidemiol. 2022 May 4;6(3):e209. doi: 10.1097/EE9.0000000000000209. eCollection 2022 Jun. Environ Epidemiol. 2022. PMID: 35702500 Free PMC article.
-
Visceral, Neural, and Immunotoxicity of Per- and Polyfluoroalkyl Substances: A Mini Review.Toxics. 2025 Jul 31;13(8):658. doi: 10.3390/toxics13080658. Toxics. 2025. PMID: 40863934 Free PMC article. Review.
References
-
- Bach CC, Bech BH, Brix N, Nohr EA, Bonde JP, Henriksen TB, 2015. Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review. Crit. Rev. Toxicol 45, 53–67. - PubMed
-
- Birukov A, Herse F, Nielsen JH, Kyhl HB, Golic M, Kraker K, et al., 2020. Blood pressure and angiogenic markers in pregnancy: contributors to pregnancy-induced hypertension and offspring cardiovascular risk. Hypertension 76, 901–909. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources